Of note, the enrichment of endothelial DMCT genes for SMAD2/3 binding targets was especially pronounced among hypermethylated sites, consistent with an interpretation in which SMAD binding and signaling is disrupted in lung cancer endothelial cells, leading to EndoMT and destruction of vascular endothelial barriers. Here, SMAD2 is linked to lung carcinoma.